Open Access

CDKN2A-rs10811661 polymorphism, waist-hip ratio, systolic blood pressure, and dyslipidemia are the independent risk factors for prediabetes in a Vietnamese population

  • Tran Quang Binh1Email author,
  • Nguyen Thi Trung Thu2,
  • Pham Tran Phuong1,
  • Bui Thi Nhung3 and
  • Trinh Thi Hong Nhung1
BMC Genetics201516:107

https://doi.org/10.1186/s12863-015-0266-0

Received: 16 April 2015

Accepted: 21 August 2015

Published: 3 September 2015

Abstract

Background

People with prediabetes are at greater risk for heart attack, stroke, kidney disease, vision problems, nerve damage and high blood pressure, compared to those without the disease. Prediabetes is a complex disorder involving both genetic and environmental factors in its pathogenesis. This cross-sectional study aimed to investigate the independent risk factors for prediabetes, considering the contribution of genetic factors (TCF7L2-rs7903146, IRS1-rs1801278, INSR-rs3745551, CDKN2A-rs10811661, and FTO-rs9939609), socio-economic status, and lifestyle factors.

Results

Among the candidate genes studied, the CDKN2A-rs10811661 polymorphism was found to be the most significant factor associated with prediabetes in the model unadjusted and adjusted for age, sex, obesity-related traits, systolic blood pressure, dyslipidemia, socio-economic status, and lifestyle factors. In the final model, the CDKN2A-rs10811661 polymorphism (OR per T allele = 1.22, 95 % CI = 1.04–1.44, P = 0.017), systolic blood pressure (OR per 10 mmHg = 1.14, 95 % CI = 1.08–1.20, P < 0.0001), waist-hip ratio (OR = 1.25, 95 % CI = 1.10–1.42, P < 0.0001), dyslipidemia (OR = 1.57, 95 % CI = 1.15–2.14, P = 0.004), and residence (OR = 1.93, 95 % CI = 2.82–4.14, P < 0.0001) were the most significant independent predictors of prediabetes, in which the power of the adjusted prediction model was 0.646.

Conclusions

The study suggested that the CDKN2A-rs10811661 polymorphism, waist-hip ratio, systolic blood pressure, and dyslipidemia were significantly associated with the increased risk of prediabetes in a Vietnamese population. The studied genetic variant had a small effect on prediabetes.

Keywords

Association study CDKN2A gene Prediabetes Single nucleotide polymorphism Vietnamese population

Background

Prediabetes is the condition where blood sugar levels are higher than normal, but not yet high enough to be classified as diabetes [1]. The importance of prediabetes has been underscored by the facts that (i) up to 70 % of people with prediabetes may develop type 2 diabetes (T2D) during their lifetimes [2]; (ii) the average time it takes a person with prediabetes to develop T2D is 3 years [3]; and (iii) people with prediabetes are at greater risk for heart attack, stroke, kidney disease, vision problems, nerve damage and high blood pressure, compared to people without the disease [4, 5]. However, prediabetes is reversible and its related metabolic disorders can be improved with proper treatment [6]. Thus, it is crucial to identify risk factors for prediabetes to prevent a person from developing this disorder.

Predisposition to prediabetes could be determined by many different combinations of genetic variants and environmental factors. Environmental factors that can increase risk for prediabetes and T2D include lifestyle habits (a sedentary lifestyle and poor nutrition, smoking and excessive alcohol consumption), overweight or obese, poor sleep, age, high blood pressure, and abnormal lipid levels [7, 8]. Genetic factors contribute to development of prediabetes and T2D. Defects in genes that encode proteins affect pathways involved in insulin control and glucose homeostasis (the balance of insulin and the hormone glucagon to maintain blood glucose), hence can raise the risk for diabetes. Such genes including INSR, IRS1, CDKN2A, TCF7L2, and FTO are also identified in genome wide association (GWA) studies [9, 10]. The contributions of these genetic variants on T2D vary among different ethnic populations because of the differences in environmental factors, risk–factor profiles, and genetic background [8, 11]. It is unclear whether these variants have the same effect in Vietnamese population, which has different socio–economic and genetic background. Moreover, the importance of each risk factor for prediabetes which varies within a specific population needs to be clarified. To date, there has been a limited data on risk factors for prediabetes in Vietnamese population. Therefore, the study was designed to investigate both genetic (TCF7L2-rs7903146, IRS1-rs1801278, INSR-rs3745551, CDKN2A-rs10811661, and FTO-rs9939609) and environmental factors for prediabetes in a Vietnamese population. The most significant factors associated with prediabetes were also reported.

Methods

Subjects and data collection

The study included 2,610 subjects (411 prediabetic cases and 2,199 normoglycemic controls). They were recruited from a cross-sectional and population-based study to be representatives of prediabetic subjects and normoglycemic controls in the general population of the Red River Delta, Vietnam. Of the total 2,610 participants, 2,608 (99.9 %) belonged to Kinh ethnic group. The Ethics Committee of the National Institute of Hygiene and Epidemiology, Vietnam approved the study. All participants provided written informed consent before entering the study. The details of the survey to collect data were reported previously [12]. In summary, data were collected on social-economic status (current age, gender, ethnicity, educational level, occupation, marital status, income level), lifestyle patterns (residence, alcohol consumption, smoking history, time spent for night’s sleep, siesta, and watching television), family history of diabetes, medical and reproductive history. Anthropometric parameters measured included weight, height, waist circumference (WC), hip circumference (HC), percent body fat, systolic blood pressure (SBP), and diastolic blood pressure (DBP). Blood samples were collected and centrifuged immediately in the morning after a participant had fasted for at least 8 h prior to the clinic visit. Plasma glucose was measured by glucose oxidase method (GOD–PAP). Lipid profile including total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) were measured by enzymatic methods. Glucose and lipid profile were analyzed using a semi–autoanalyzer (Screen Master Lab; Hospitex Diagnostics LIHD112, Italy) with commercial kit (Chema. Diagnostica, Italy). Dyslipidemia [13] is defined as HDL-C < 40 mg/dL for men and < 50 mg/dL for women, and TC, LDL-C and TG levels ≥ 200, ≥ 130 and ≥ 130 mg/dL, respectively.

The glycaemic status of subjects was determined using fasting plasma glucose level (FPG) and oral glucose tolerance test (OGTT) with 75 g glucose [14]. Participants were classified as having diabetes if they had FPG ≥ 7.0 mmol/l or 2-h plasma glucose ≥ 11.1 mmol/l or previous diagnosis of diabetes and current use of drug for its treatment. Normal glucose tolerance (NGT) was classified when FPG < 5.6 mmol/l and 2-h plasma glucose < 7.8 mmol/l. Isolated impaired fasting glucose (IFG) was identified if FPG was between 5.6 and 6.9 mmol/l, and 2-h plasma glucose was less than 7.8 mmol/l. Isolated impaired glucose tolerance (IGT) was classified if FPG was less than 5.6 mmol/l and 2-h plasma glucose was between 7.8 and 11.0 mmol/l. Combined IFG and IGT (IFG − IGT) were determined if FPG was between 5.6 and 6.9 mmol/l, and 2-h plasma glucose was between 7.8 and 11.0 mmol/l. Prediabetic status included IFG and/or IGT.

Genotyping

Peripheral blood samples were obtained from each participant and genomic DNA was extracted from peripheral blood leukocytes, using Wizard® Genomic DNA Purification Kit (Promega Corporation, USA). Primers, protocols of polymerase chain reaction, and restriction enzymes for genotyping the polymorphisms are presented in Additional file 1. Our typing strategy was to use the allele–specific primer (ASP) typing method [15], then 10 % of all samples were typed using restriction fragment length polymorphism (RFLP) analysis to validate observed results. There were more than 98 % agreement of the result between ASP typing method and RFLP analysis in the samples checked. In addition, samples were selected randomly and re-genotyped using the original platform. The results showed that the concordance rate was 96–99 % with respect to the 30 % of samples genotyped twice for quality control.

Statistical analysis

Genotypes were coded as 0, 1, and 2, depending on the number of copies of risk alleles. Genotype frequencies were compared and tested for Hardy–Weinberg equilibrium (HWE) by Fisher’s exact test. Five genetic models were tested (dominant, co-dominant, over-dominant, recessive, and additive model). Akaike’s Information Criterion and Bayesian Information Criterion were applied to estimate the best-fit model for each SNP. The procedure was performed in SNPstat software [16].

Quantitative variables were checked for normal distribution and compared using Mann–Whitney U test. Binary logistic regression analysis was used to test several models for the associations of prediabetes with the risk alleles and other variables, taken into account the covariates (age, sex, socio-economic status, lifestyle factors, obesity–related traits (BMI, WC, HC, WHR, and percent body fat), systolic blood pressure, and lipid profile). The variables included in the analyses were checked for multicollinearity to ensure the stability of the parameter estimates. Here, data are presented as odds ratios with 95 % confidence intervals (CI). In order to assess the model performance, a receiver operating characteristic (ROC) curve was built to plot probabilities resulted from the multivariate logistic regression analysis, and the area under ROC curve (AUC) was used to measure the power to predict individuals with prediabetes. The level of significance was set to 0.05 for all analyses. The above statistical procedures were performed using SPSS version 16.0 (SPSS, Chicago, USA). The Bayesian model averaging was used to cross-validate the final model using Bayesian Model Averaging Software with the R Statistical Environment version 3.1.3 [17].

Results

Characteristics of the study subjects

Of the 2,610 participants recruited into the study, 65.4 % were women, 72.6 % were farmers, and 72.2 % had elementary or intermediate levels of education. The characteristics of subjects in prediabetic cases and controls are shown in Table 1. There were significant differences between prediabetic and control groups in age, BMI, waist circumference, WHR, systolic blood pressure, diastolic blood pressure, total cholesterol, HDL − C, and triglyceride. Significant differences between cases and controls were not found in gender, height, weight, body fat percent, hip circumference, nutrition status, and LDL − C.
Table 1

Characteristics of subjects in prediabetic cases and controls

Characteristics

Prediabetic cases

Controls

Total

P − value

(N = 411)

(N = 2199)

(N = 2610)

Male, n (%)

152 (37 %)

752 (34.2 %)

904 (34.6 %)

0.276

Age (year)

53 (47–57.8)

51 (46–56)

51 (46–56)

<0.0001

Weight (kg)

51.8 (46–57.9)

51(46.3 − 56.5)

51 (46.2 − 56.6)

0.117

Height (cm)

155.5 (150.5 − 160)

155 (150.7 − 160)

155 (150.6 − 160

0.731

Body mass index (kg/m2)

21.5 (19.6 − 23.4)

21.1 (19.3 − 22.9)

21.2 (19.4 − 23)

0.012

Body fat (%)

28.2 (23.7 − 31.9)

27.5 (22.9 − 31.5)

27.6 (23.2 − 31.6)

0.119

Waist circumference (cm)

75 (69–82)

73.5 (68.5 − 79)

74 (68.5 − 79.5)

0.002

Hip circumference (cm)

88 (84–92)

88 (84–91.3)

88 (84–91.5)

0.628

Waist − hip ratio

0.85 (81–0.90)

0.84(0.80 − 0.88)

0.84 (0.80 − 0.88)

<0.0001

Nutrition status

 Normal

237 (57.8)

1342 (61.4)

1579 (60.8)

0.129

 Overweight

77 (18.8)

344 (15.7)

421 (16.2)

 

 Obesity

44 (10.7)

183 (8.4)

227 (8.7)

 

 Underweight

52 (12.7)

316 (14.5)

368 (14.2)

 

Systolic blood pressure (mmHg)

120 (110–137.5)

110.3 (100–127.5)

115 (110–130)

<0.0001

Diastolic blood pressure (mmHg)

80 (70–85)

70 (65–80)

70 (65–80)

<0.0001

Total cholesterol (mmol l−1)

4.60 (4.09 − 5.00)

4.20 (3.85 − 4.87)

4.30 (3.90 − 4.90)

<0.0001

HDL − C (mmol l−1)

1.19 (0.97 − 1.60)

1.23 (0.99 − 1.60)

1.22 (0.98 − 1.60)

<0.0001

LDL − C (mmol l−1)

3.10 (2.64 − 3.70)

2.79 (2.31 − 3.31)

2.83 (2.34 − 3.40)

0.103

Triglyceride (mmol l−1)

1.80 (1.12 − 2.55)

1.34 (1.00 − 2.02)

1.41 (1.01 − 2.10)

<0.0001

HDL − C, high-density lipoprotein − cholesterol; LDL − C, low-density lipoprotein − cholesterol. Quantitative data are median (interquartile range). Qualitative data are number (%). P-value by Mann–Whitney U test or chi-square test

Associated factors for prediabetes

Socioeconomic status (age, marital status), lifestyle patterns (residence, alcohol consumption), anthropometric traits (BMI, WC, WHR, and SBP), and lipid profile (TC, TG, and LDL-C) were significantly associated with prediabetes in univariate logistic regression (Additional file 2). The analysis of the best-fit model for individual SNPs in candidate genes with prediabetes among genetic models of inheritance (additive, codominant, dominant, overdominant, and recessive) is shown in Additional file 3. The lowest values of both Akaike’s Information Criterion and Bayesian Information Criterion were only found in the additive model, indicating this best-fit model in all studied SNPs.

The association of prediabetes with residence, marital status, alcohol consumption, WHR, SBP, dyslipidemia, and CDKN2A-rs10811661 polymorphism was observed in multivariate analysis (Table 2), considering the contribution of genetic factors, anthropometric measurements, lipid profile, socio-economic status and lifestyle factors. The prediction model using the most significant predictors of prediabetes is presented in Table 3. In the final model, the CDKN2A-rs10811661 polymorphism (OR per T allele = 1.22, 95 % CI = 1.04–1.44, P = 0.017), systolic blood pressure (OR per 10 mmHg = 1.14, 95 % CI = 1.08–1.20, P < 0.0001), waist–hip ratio (OR = 1.25, 95 % CI = 1.10–1.42, P < 0.0001), dyslipidemia (OR = 1.57, 95 % CI = 1.15–2.14, P = 0.004), and residence (OR = 1.93, 95 % CI = 2.82–4.14, P < 0.0001) were the most significant independent predictors of prediabetes. The independent variables in the final model were also confirmed using the Bayesian model averaging (Additional file 4). The area under ROC curve for the prediction model of prediabetes on the predictors including residence, waist-hip ratio, and systolic blood pressure, dyslipidemia and CDKN2A-rs10811661 polymorphism was 0.646 (95 % CI: 0.614 − 0.677, P < 0.0001). Adding the genetic marker to the clinical covariates improved the area under ROC curve slightly from 0.637 to 0.646 (P < 0.019, Wilcoxon Signed Ranks Test) (Fig. 1).
Table 2

Multivariate analysis of association for prediabetes

Variable

OR (95 % CI)

P-value

Variable

OR (95 % CI)

P-value

Sex

Residence

 Female

1

 

 Rural

1

 

 Male

0.78 (0.45–1.33)

0.354

 Urban

3.95 (2.50–6.23)

<0.0001

Age (year)

1.02 (0.99–1.04)

0.075

Alcohol consumption

  

Marital status

  

 None

1

 

 Married

1

 

  < 1 drink/mo

1.14 (0.62–2.09)

0.686

 Never

2.14 (1.01–4.55)

0.048

  ≥ 1 drink/mo to < 1 drink/wk

2.02 (1.15–3.56)

0.015

 Widowed

0.92 (0.53–1.60)

0.766

 1 drink/wk to ≤ 1 drink/d

1.49 (0.87–2.55)

0.147

 Others

0.87 (0.29–2.57)

0.800

  ≥ 2 drink/d

2.06 (1.16–3.68)

0.014

Education level

  

Smoking

  

 Elementary

1

 

 None

1

 

 Intermediate

0.97 (0.63–1.50)

0.904

 Current smoker

0.75 (0.44–1.28)

0.293

 Secondary

0.99 (0.56–1.76)

0.987

 Ex–smoker

1.01 (0.57–1.77)

0.987

 Post–secondary

0.89 (0.48–1.62)

0.691

Watching televison time/day

  

Heavy occupation

  

  ≤ 3 h

1

 

 Yes

1

 

  > 3 h

0.81 (0.44–1.51)

0.513

 No

0.95 (0.64–1.41)

0.800

Sleeping time/day

  

Income level

  

 6–7 h

1

 

  < 25 percentiles

1

 

  < 6 h

0.90 (0.62–1.31)

0.584

 25– < 50 percentiles

1.25 (0.86–1.82)

0.246

  ≥ 8 h

0.99 (0.72–1.39)

0.996

 50–75 < percentiles

0.94 (0.63–1.40)

0.749

Sitting time/day

  

  ≥ 75 percentiles

0.99 (0.67–1.48)

0.984

  ≤ 4 h

1

 
   

  > 4 h

0.96 (0.73–1.28)

0.790

Systolic blood pressure (SD = 10 mmHg)

1.11 (1.04–1.19)

0.001

Siesta time/day (SD = 15 min)

1.08 (1.01–1.15)

0.020

Dyslipidemia

  

Each of the following obesity-related measurements:

 No

1

 

 Waist-hip ratio (SD = 0.07)

1.21 (1.03–1.41)

0.019

 Yes

1.48 (1.04–2.09)

0.027

 Waist circumference (SD = 7 cm)

1.12 (0.98–1.27)

0.086

CDKL2A-rs10811661 per copy of T allele

1.23 (1.03–1.46)

0.022

 Hip circumference (SD = 7 cm)

1.01 (0.85–1.21)

0.873

TCF7L2-rs7903146 per copy of T allele

1.13 (0.64–2.01)

0.676

 Body mass index (SD = 0.25 kg/m2)

1.12 (0.99–1.28)

0.079

IRS1-rs1801278 per copy of G allele

1.01 (0.57–1.79)

0.967

 Body fat (SD = %)

1.22 (0.90–1.66)

0.206

INSR-rs3745551 per copy of G allele

1.05 (0.86–1.27)

0.648

   

FTO-rs9939609 per copy of A allele

0.98 (0.79–1.22)

0.852

   

SD, standard deviation. One drink was defined as a 50–ml cup of rice wine at about 30 %

Table 3

The most significant independent predictors of prediabetes

Variable

Unit

Coefficient

Odds ratio (95 % CI)

P–value

Waist to hip ratio

0.07

0.224

1.25 (1.10 − 1.42)

<0.0001

Systolic blood pressure

10 mmHg

0.124

1.13 (1.07 − 1.20)

<0.0001

Dyslipidemia

0 = no, 1 = yes

0.453

1.57 (1.15 − 2.14)

0.004

Residence

0 = rural, 1 = urban

1.038

1.93 (2.82 − 4.14)

<0.0001

CDKN2A-rs10811661

Number of T allele

0.201

1.22 (1.04 − 1.44)

0.017

Intercept

 

−6.581

-

<0.0001

P-value by multivariate logistic regression

Fig. 1

ROC curvers for the prediction models on the number of risk allele of CDKN2A-rs10811661, residence, waist-hip ratio, systolic blood pressure, and dyslipidemia in model 2 and model 1 without genetic marker

Discussion

Of the 5 candidate SNPs tested for association, we found that the CDKN2A-rs10811661 polymorphism was significantly associated with prediabetes in a Vietnamese population, independent of obesity-related traits, considering the influence of the socio-economic status and lifestyle factors. The association of the CDKN2A-rs10811661 polymorphism with T2D was initially reported in White populations [1820], and subsequently replicated in Asian populations [2123]. The CDKN2A-rs10811661 polymorphism was significantly associated with T2D in Japaneses (OR = 1.25, 95 % CI = 1.08–1.45, P = 0.0024) [22], and in Indians (OR = 1.37, 95 % CI = 1.18–1.59, P = 5.1E-05) [24]. In Chinese populations, the CDKN2A-rs10811661 polymorphism was associated with increased risk in both prediabetes (OR = 1.23, 95 % CI = 1.11–1.36) and T2D (OR = 1.46, 95 % CI = 1.01–2.11) in a case–control study and confirmed in a prospective study that the risk allele of rs10811661 increased the risk of incident T2D by 94 % [25]. Moreover, in GWA studies in Asians, the variant was associated with T2D in East Asians (Han Chinese and Japanese) (OR = 1.23, 95 % CI = 1.18–1.29, P = 1.43E-18) [26], and a large multi-center GWA study replicated the association in both East Asians (OR = 1.25, 95 % CI = 1.17–1.32, P = 6.3E-13) and South Asians (OR = 1.20, 95 % CI = 1.11–1.31, P = 1.4E-05) [27]. These studies showed that the effect of the variant in CDKN2A gene seemed slightly higher in T2D compared to prediabetes in the present study (OR = 1.22, 95 % CI = 1.04–1.44, P = 0.017). On the other hand, this polymorphism was not associated with prediabetes in German people [28]. Given the multifactorial pattern of prediabetes, the contribution of the CDKN2A-rs10811661 polymorphism varies among populations depending on the socio–economic status, lifestyle factors, genetic background, and risk − factor profile of each population [29].

There were many factors influencing the association between the CDKN2A-rs10811661 polymorphism and prediabetes, including bias selection of subjects, confounding factors such as socio–economic condition, and lifestyle factors. The bias selection in the study was controlled since the subjects were recruited from the population − based screening survey with a sample size representative of all prediabetic cases and normoglycemic controls in the general population. Moreover, given the multifactorial nature of prediabetes, the association in our study was investigated in several analysis models, which considered the various factors including sex, age, systolic blood pressure, obesity − related traits (BMI, WC, WHR, and body fat percentage), socio–economic patterns (occupation, education level, residence, marital status, income level), and lifestyle factors (smoking, alcohol consumption, leisure time spent sitting, watching TV, and siesta). Thereby, the statistically significant association between the CDKN2A-rs10811661 polymorphism and prediabetes was found to be independent of the traditional risk factors.

Regarding the allele and genotype frequencies of the CDKN2A-rs10811661 polymorphism, we found that the risk T allele frequency was 57.6 %, and the frequencies of CC, CT, and TT genotypes were 18.9, 46.9, and 34.2 %, respectively in the total sample. The allele and genotype frequencies in our sample were similar to those in Asian populations (Han Chinese: 57 %, Japanese: 52.4 %) and different from those in European (77.8–80.1 %) and African (89–98.2 %) populations based on HapMap data [30].

Being obesity, which is associated with insulin resistance and dysfunction of beta cell, is one of the most important risk factors for the development of prediabetes [31]. Among obesity-related traits, WHR was recognized to be the most significantly associated with prediabetes in our population. In the present study, the association between the CDKN2A-rs10811661 polymorphism and prediabetes was consistently significant when adding each of the obesity − related traits in the analysis models including age, gender, systolic blood pressure, socio-economic status and lifestyle factors, indicating the direct effect of the CDKN2A-rs10811661 polymorphism on prediabetes, independently of the obesity–related traits.

In terms of predictors of prediabetes, few genetic studies have been reported although the importance of prediabetes has been underscored. The present data showed an increased prediabetes risk with an additive effect of the alleles of CDKN2A-rs10811661 (OR per T allele = 1.22, 95 % CI = 1.04–1.44, P = 0.017). Our finding supports the association of the CDKN2A-rs10811661 polymorphism with prediabetes reported in previous case–control studies in Asian populations [22, 23, 25, 28]. Moreover, the predictive effect of the CDKN2A-rs10811661 polymorphism on the incident T2D was also confirmed in a 3.5 year follow-up study [28]. These findings can be explained by the evidences that a reduced insulin release was observed for the CDKN2A-rs10811661 T-allele after both oral and intravenous glucose challenges [20] and that the SNP was significantly associated with early-phase insulin release [32]. Among the independent risk factors for prediabetes, WHR, dyslipidemia, and systolic blood pressure demonstrated the strongest effects in our findings, which is in agreement with previous studies [3335]. Adding the genetic marker to the clinical covariates in our study improved slightly the area under the receiver operating characteristic curve from 0.637 to 0.646 (P < 0.019), indicating that the studied variant had a small effect on prediabetes.

Indeed, some advantages could be highlighted in this study. Since this is a large population-based study in the Red River Delta region, Vietnam, the findings of the study will be interpreted for general population of this region in both genetic pattern and risk factor profile. The studied population could be considered as a homogeneous sample of the Kinh ethnic adults aged 40–64 years in a rural province without other ethnic admixtures. Prediabetes including IFG and/or IGT was determined using fasting plasma glucose level and oral glucose tolerance test with 75 g glucose. This method has been widely accepted and frequently referred as the “gold standard” for diagnosis of prediabetes. However, several limitations should be noted in this study. First, the limitation of the cross-sectional study design does not allow for conclusions of the causal relationships. Next, among many candidate SNPs have been proposed to be associated with T2D and prediabetes, the present study was only interested in 5 SNPs in genes related to insulin pathway, and thereby the studied genetic variant had a small effect on prediabetes despite statistical significance. Lastly, the area under ROC curve of 0.646 shows the poor power of prediction of the model.

Conclusions

These data demonstrate that the CDKN2A-rs10811661 polymorphism, waist–hip ratio, systolic blood pressure, and dyslipidemia were significantly associated with the increased risk of prediabetes in a Vietnamese population. The association remains consistent after adjustment for age, gender, socio-economic status, and lifestyle-related factors. Because of the small contribution of the single CDKN2A–rs10811661 polymorphism, it is necessary to conduct a large-scale prospective study on prediabetes and T2D in Vietnamese population.

Abbreviations

BMI: 

Body mass index

CI: 

Confidence interval

DBP: 

Diastolic blood pressure

HC: 

Hip circumference

HDL-C: 

High-density lipoprotein cholesterol

IGT: 

Impaired glucose tolerance

IFG: 

Impaired fasting glucose

LDL-C: 

Low-density lipoprotein cholesterol

OGTT: 

Oral glucose tolerance test

OR: 

Odds ratio

RFLP: 

Restriction fragment length polymorphism

SBP: 

Systolic blood pressure

TC: 

Total cholesterol

T2D: 

Type 2 diabetes

TG: 

Triglycerides

WC: 

Waist circumference

WHR: 

Waist–hip ratio

Declarations

Acknowledgments

The authors would like to thank Dr. Dang Dinh Thoang, Dr. Pham Van Thang, and Mrs. Nguyen Minh Thai for kindly helps and supports. We acknowledge the health staff of the Ha Nam Center for Preventive Medicine for their cooperation and assistance.

This study was supported by Vietnam’s National Foundation for Science and Technology Development (NAFOSTED), grant no. 106.09-2012.04 from the Ministry of Science and Technology, Vietnam.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
National Institute of Hygiene and Epidemiology
(2)
Hanoi National University of Education
(3)
National Institute of Nutrition

References

  1. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002;55(1):65–85.View ArticlePubMedGoogle Scholar
  2. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007;30(3):753–9.View ArticlePubMedGoogle Scholar
  3. Nichols GA, Hillier TA, Brown JB. Progression from newly acquired impaired fasting glusose to type 2 diabetes. Diabetes Care. 2007;30(2):228–33.PubMed CentralView ArticlePubMedGoogle Scholar
  4. Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation. 2007;116(2):151–7.View ArticlePubMedGoogle Scholar
  5. Buysschaert M, Medina JL, Bergman M, Shah A, Lonier J. Prediabetes and associated disorders. Endocrine. 2014;1–23. doi:10.1007/s12020-014-0436-2.
  6. Tuso P. Prediabetes and lifestyle modification: time to prevent a preventable disease. Perm J. 2014;18(3):88–93.PubMed CentralView ArticlePubMedGoogle Scholar
  7. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129–40.View ArticlePubMedGoogle Scholar
  8. Weber MB, Oza–Frank R, Staimez LR, Ali MK, Narayan KM. Type 2 diabetes in Asians: prevalence, risk factors, and effectiveness of behavioral intervention at individual and population levels. Annu Rev Nutr. 2012;32:417–39.View ArticlePubMedGoogle Scholar
  9. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445:881–5.View ArticlePubMedGoogle Scholar
  10. Basile KJ, Johnson ME, Xia Q, Grant SF. Genetic susceptibility to type 2 diabetes and obesity: follow-up of findings from genome-wide association studies. Int J Endocrinol. 2014;2014:769671. doi:10.1155/2014/769671.PubMed CentralView ArticlePubMedGoogle Scholar
  11. Saxena R, Elbers CC, Guo Y, Peter I, Gaunt TR, Mega JL, et al. Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet. 2012;90:410–25.PubMed CentralView ArticlePubMedGoogle Scholar
  12. Quang Binh T, Tran Phuong P, Thi Nhung B, Dinh Thoang D, Van Thang P, Khanh Long T, et al. Prevalence and correlates of hyperglycemia in a rural population, Vietnam: implications from a cross-sectional study. BMC Public Health. 2012;12:939.PubMed CentralView ArticlePubMedGoogle Scholar
  13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97. doi:10.1001/jama.285.19.2486
  14. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO consultation. Geneva: World Health Organization; 2006.Google Scholar
  15. Wangkumhang P, Chaichoompu K, Ngamphiw C, Ruangrit U, Chanprasert J, Assawamakin A, et al. WASP: a Web–based Allele–Specific PCR assay designing tool for detecting SNPs and mutations. BMC Genomics. 2007;8:275. doi:10.1186/1471-2164-8-275.PubMed CentralView ArticlePubMedGoogle Scholar
  16. Solé X, Guinó E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22(15):1928–9.View ArticlePubMedGoogle Scholar
  17. Team RC. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2015. http://www.R-project.org/.
  18. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316(5829):1341–5.PubMed CentralView ArticlePubMedGoogle Scholar
  19. Grarup N, Rose CS, Andersson EA, Andersen G, Nielsen AL, Albrechtsen A, et al. Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies. Diabetes. 2007;56(12):3105–11.View ArticlePubMedGoogle Scholar
  20. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007;316:1336–41.PubMed CentralView ArticlePubMedGoogle Scholar
  21. Ng MCY, Park KS, Oh B, Tam CHT, Cho YM, Shin HD, et al. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes. 2008;57:2226–33.PubMed CentralView ArticlePubMedGoogle Scholar
  22. Omori S, Tanaka Y, Takahashi A, Hirose H, Kashiwagi A, Kaku K, et al. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes. 2008;57:791–5.View ArticlePubMedGoogle Scholar
  23. Wu Y, Li H, Loos RJ, Yu Z, Ye X, Chen L, et al. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes. 2008;57(10):2834–42.PubMed CentralView ArticlePubMedGoogle Scholar
  24. Ganesh C, Charles US, Rubina T, Seema B, Smita RK, Anubha M, et al. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2 and CDKAL1 on the risk of type 2 diabetes in 5.164 Indians. Diabetes. 2010;59:2068–74.View ArticleGoogle Scholar
  25. Xu M, Bi Y, Xu Y, Yu B, Huang Y, Gu L, et al. Combined effects of 19 common variations on type 2 diabetes in Chinese: results from two community-based studies. PLoS One. 2010;5(11):e14022. doi:10.1371/journal.pone.001402221103332.PubMed CentralView ArticlePubMedGoogle Scholar
  26. Hara K, Fujita H, Johnson TA, Yamauchi T, Yasuda K, Horikoshi M, et al. Genome-wide association study identifies three novel loci for type 2 diabetes. Hum Mol Genet. 2014;23(1):239–46. doi:10.1093/hmg/ddt399.View ArticlePubMedGoogle Scholar
  27. DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium, South Asian Type 2 Diabetes (SAT2D) Consortium, Mexican American Type 2 Diabetes (MAT2D) Consortium, Type 2 Diabetes Genetic Exploration by Nex-generation sequencing inmuylti-Ethnic Samples (T2D-GENES) Consortium, et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet. 2014;46(3):234–44. doi:10.1038/ng.2897.View ArticleGoogle Scholar
  28. Zyriax B-C, Salazar R, Hoeppner W, Vettorazzi E, Herder C, Windler E. The association of genetic markers for type 2 diabetes with prediabetic status - cross-sectional data of a diabetes prevention trial. PLoS One. 2013;8(9):e75807. doi:10.1371/journal.pone.0075807.PubMed CentralView ArticlePubMedGoogle Scholar
  29. Adeyemo A, Rotimi C. Genetic variants associated with complex human diseases show wide variation across multiple populations. Public Health Genomics. 2010;13:72–9.View ArticlePubMedGoogle Scholar
  30. Sherry ST, Ward M and Sirotkin K. dbSNP–Database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Res. 1999;9:677–9.Google Scholar
  31. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106(4):473–81.PubMed CentralView ArticlePubMedGoogle Scholar
  32. Stančáková A, Kuulasmaa T, Paananen J, Jackson AU, Bonnycastle LL, Collins FS, et al. Association of 18 confirmed susceptibility Loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men. Diabetes. 2009;58(9):2129–36.PubMed CentralView ArticlePubMedGoogle Scholar
  33. Khambalia A, Phongsavan P, Smith BJ, Keke K, Dan L, Fitzhardinge A, et al. Prevalence and risk factors of diabetes and impaired fasting glucose in Nauru. BMC Public Health. 2011;11:719. doi:10.1186/1471-2458-11-719.PubMed CentralView ArticlePubMedGoogle Scholar
  34. Soriguer F, Goday A, Bosch-Comas A, Bordiú E, Calle-Pascual A, Carmena R, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The Di@bet.es Study. Diabetologia. 2012;55:88–93.PubMed CentralView ArticlePubMedGoogle Scholar
  35. Díaz-Redondo A, Giráldez-García C, Carrillo L, Serrano R, García-Soidán F, Artola S, et al. Modifiable risk factors associated with prediabetes in men and women: a cross-sectional analysis of the cohort study in primary health care on the evolution of patients with prediabetes (PREDAPS-Study). BMC Fam Pract. 2015;16:5. doi:10.1186/s12875-014-0216-3.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Binh et al. 2015

Comments